BACKGROUND: How case volume and quality of care relate to each other and to results of complex cancer surgery is not well-understood. STUDY DESIGN: Observational cohort of 14,170 patients 18 years or older who underwent pneumonectomy, esophagectomy, pancreatectomy, or pelvic surgery for cancer between October 1, 2003 and September 1, 2005 at a US hospital participating in a large benchmarking database. Case volumes were estimated within our dataset. Quality was measured by determining whether ideal patients did not receive appropriate perioperative medications (such as antibiotics to prevent surgical site infections), both as individual "missed"measures and as overall number missed. We used hierarchical models to estimate effects of volume and quality on 30-day readmission, in-hospital mortality, length of stay, and costs. RESULTS: After adjustment, we noted no consistent associations between higher hospital or surgeon volume and mortality, readmission, length of stay, or costs. Adherence to individual measures was not consistently associated with improvement in readmission, mortality, or other outcomes. For example, continuing antimicrobials past 24 hours was associated with longer length of stay (21.5% higher, 95% CI, 19.5-23.6%) and higher costs (17% higher, 95% CI, 16-19%). In contrast, overall adherence, although not associated with differences in mortality or readmission, was consistently associated with longer length of stay (7.4% longer with 1 missed measure and 16.4% longer with ≥2) and higher costs (5% higher with 1 missed measure, and 11% higher with ≥2). CONCLUSIONS: Although hospital and surgeon volume were not associated with outcomes, lower overall adherence to quality measures is associated with higher costs, but not improved outcomes. This finding might provide a rationale for improving care systems by maximizing care consistency, even if outcomes are not affected.
BACKGROUND: How case volume and quality of care relate to each other and to results of complex cancer surgery is not well-understood. STUDY DESIGN: Observational cohort of 14,170 patients 18 years or older who underwent pneumonectomy, esophagectomy, pancreatectomy, or pelvic surgery for cancer between October 1, 2003 and September 1, 2005 at a US hospital participating in a large benchmarking database. Case volumes were estimated within our dataset. Quality was measured by determining whether ideal patients did not receive appropriate perioperative medications (such as antibiotics to prevent surgical site infections), both as individual "missed"measures and as overall number missed. We used hierarchical models to estimate effects of volume and quality on 30-day readmission, in-hospital mortality, length of stay, and costs. RESULTS: After adjustment, we noted no consistent associations between higher hospital or surgeon volume and mortality, readmission, length of stay, or costs. Adherence to individual measures was not consistently associated with improvement in readmission, mortality, or other outcomes. For example, continuing antimicrobials past 24 hours was associated with longer length of stay (21.5% higher, 95% CI, 19.5-23.6%) and higher costs (17% higher, 95% CI, 16-19%). In contrast, overall adherence, although not associated with differences in mortality or readmission, was consistently associated with longer length of stay (7.4% longer with 1 missed measure and 16.4% longer with ≥2) and higher costs (5% higher with 1 missed measure, and 11% higher with ≥2). CONCLUSIONS: Although hospital and surgeon volume were not associated with outcomes, lower overall adherence to quality measures is associated with higher costs, but not improved outcomes. This finding might provide a rationale for improving care systems by maximizing care consistency, even if outcomes are not affected.
Authors: Caprice K Christian; Michael L Gustafson; Rebecca A Betensky; Jennifer Daley; Michael J Zinner Journal: Ann Surg Date: 2003-10 Impact factor: 12.969
Authors: Lee A Jennings; Andrew D Auerbach; Judith Maselli; Penelope S Pekow; Peter K Lindenauer; Sei J Lee Journal: J Am Geriatr Soc Date: 2010-04 Impact factor: 5.562
Authors: Philip P Goodney; Andrea E Siewers; Therese A Stukel; F Lee Lucas; David E Wennberg; John D Birkmeyer Journal: J Am Coll Surg Date: 2002-08 Impact factor: 6.113
Authors: Deborah Schrag; Katherine S Panageas; Elyn Riedel; Lillian Hsieh; Peter B Bach; Jose G Guillem; Colin B Begg Journal: J Surg Oncol Date: 2003-06 Impact factor: 3.454
Authors: David C Hodgson; Wei Zhang; Alan M Zaslavsky; Charles S Fuchs; William E Wright; John Z Ayanian Journal: J Natl Cancer Inst Date: 2003-05-21 Impact factor: 13.506
Authors: John D Birkmeyer; Therese A Stukel; Andrea E Siewers; Philip P Goodney; David E Wennberg; F Lee Lucas Journal: N Engl J Med Date: 2003-11-27 Impact factor: 91.245
Authors: Jennie K Lee; Aristithes G Doumouras; Jeremy E Springer; Cagla Eskicioglu; Nalin Amin; Margherita Cadeddu; Dennis Hong Journal: Surg Endosc Date: 2019-06-10 Impact factor: 4.584
Authors: Felix G Fernandez; Onkar Khullar; Seth D Force; Renjian Jiang; Allan Pickens; David Howard; Kevin Ward; Theresa Gillespie Journal: Ann Thorac Surg Date: 2014-11-11 Impact factor: 4.330
Authors: Claudia Fischer; Hester F Lingsma; Perla J Marang-van de Mheen; Dionne S Kringos; Niek S Klazinga; Ewout W Steyerberg Journal: PLoS One Date: 2014-11-07 Impact factor: 3.240
Authors: James Studnicki; Christopher Craver; Christopher M Blanchette; John W Fisher; Sara Shahbazi Journal: BMC Surg Date: 2014-08-16 Impact factor: 2.102
Authors: Navneet S Majhail; Lih-Wen Mau; Pintip Chitphakdithai; Ellen M Denzen; Steven Joffe; Stephanie J Lee; Charles F LeMaistre; Fausto Loberiza; Susan K Parsons; Ramona Repaczki-Jones; Pam Robinett; J Douglas Rizzo; Elizabeth Murphy; Brent Logan; Jennifer Le-Rademacher Journal: Bone Marrow Transplant Date: 2019-11-18 Impact factor: 5.483